Trends tend to turn out to be FACTS a lot of the time. The old saying, "the trend is your friend". When you observe and learn from history, you will not make the same mistakes.
What has happend with MRKR for the last year is no suprise at all. If fact, what has played out has been posted on this board, in advance, many times (Phantom said many times that Active AML was a tough nut to crack and he was concerned with financing/cash burn rate/trial delays etc).
Advise given on this board on 12-29-22 when share price was 24 cents (equivalent to $2.40 post RS) was "a reverse split is happening very soon and after the RS that new share price with Drop Down Further, so you might be better off waiting until after the RS to get a better price on a per share basis."
Posted on 2-11-23 to a question of "when to buy", answer was "After a 60+% pull back from the RS. Below $1.50, That's what I'm waiting for. Without great news which is not coming anytime soon, it will be a slow trickle down in price."
Well, after the RS, we went down to 1/3 of that $2.40 and are now at about 1/2 of that $2.40.
Here's a FACT, most times with a tiny company, when they do a RS, the short sellers smell blood and pile in. It is almost never fully "factored in to the PPS" before the RS, and most times after a RS it CONTINUES TO GO DOWN FURTHER.
Well, we got some good news with the Vera/Wilson deal and the share price went up a bit.
And a good chunk of it was day traders smelling quick in and out and in and out profits.
And over time they fade away and move on to the next target.
We now have financing through 2024 at least so for now, Financing no longer an issue, which was NOT the case at all in Dec. 2022.
But we also have a potential data/news desert for the rest of 2023 and most of 2024 until adjuvant AML news.
What will happen to share price till then? No day traders to prop it up. A few shorts might come back to try to earn their pennies.
Many traders go with another old saying "buy on the rumor, sell on the news".
As far as MRKR, I'm not a trader, just a holder, was never much for the strategy of "buy higher before the RS, sell lower after the price drops even further post RS as expected".
My last MRKR buy as posted was at $1.11 on 3-23-2023, post RS as the price tumbled down still futher as expected.
So where does the price go from here? In the absence of any good news, history would tell me downward trickle over time.
I hope we can hold above $1.
I would love to hear Vera give us a somewhat ACCURATE estimate on when will can MAYBE expect some adjuvant AML data/news.
I think that will hold more weight than any preliminary early lymphoma or pancreatic news.
We had the Kentucky Derby ran this past weekend. Now that PH is GONE as CEO, (THANK YOU), MRKR reminds me of another old saying about thoroughbred horses, "breed the best to the best and hope for the best".
GOOD LUCK TO ALL.
